心通口服液治疗冠心病心绞痛患者临床疗效观察.docVIP

心通口服液治疗冠心病心绞痛患者临床疗效观察.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
心通口服液治疗冠心病心绞痛患者临床疗效观察

心通口服液治疗冠心病心绞痛患者临床疗效观察   【摘要】 目的:探讨心通口服液治疗冠心病心绞痛患者的临床疗效。方法:回顾性分析2010年2月-2013年2月本院收治的72例冠心病心绞痛患者的临床资料,根据治疗方法的不同分为治疗组和对照组各36例,其中治疗组给予心通口服液治疗,对照组给予三酰甘油片治疗,比较两组患者的临床疗效、治疗前后心绞痛频率、心肌耗氧量和治疗后血液黏度以及血小板聚集指数。结果:治疗组总有效率97.22%明显高于对照组的77.78%,比较差异有统计学意义(P0.05),治疗后治疗组的心绞痛频率、心肌耗氧量均明显低于对照组,且治疗后治疗组的血液黏度和血小板聚集指数均明显低于对照组,比较差异均有统计学意义(P0.05)。结论:心通口服液治疗冠心病心绞痛可明显降低患者的心绞痛频率和心肌耗氧量,临床疗效显著,值得在临床上推广。   【关键词】 心通口服液; 冠心病心绞痛; 临床疗效   【Abstract】 Objective:To explore the clinical efficacy of Xintong oral liquid in the treatment of patients with angina coronary heart disease.Method:The clinical data of 72 patients with angina pectoris admitted to our hospital were retrospective analyzed.According to different methods of treatment methods,they were divided into the treatment group and the control group,37 cases in each group.The treatment group was treated with Xintong oral liquid,and the control group was taken with triglycerides for treatment.The clinical curative effect,frequency of angina and myocardial oxygen consumption before and after treatment and post-treatment platelet aggregation and blood viscosity index for the two groups were compared.Result:The total effective rate in the treatment group was 97.22%,it was significantly higher than the 77.78% of the control group,the difference was statistically significant(P0.05).After treatment,the frequency of angina and myocardial oxygen consumption in treatment group were significantly lower than those of control group,and blood viscosity and platelet aggregation index in treatment group after treatment were significantly lower than those of control group,the differences were statistically significant(P0.05).Conclusion:Xintong oral liquid in the treatment of patients with angina coronary heart disease can significantly reduce the frequency of angina and myocardial oxygen consumption,and clinical effect is significant.It is worth promoting in clinical practice.   【Key words】 Xintong oral liquid; Angina pectoris; Clinical efficacy   冠心病心绞痛在老年病中较为常

文档评论(0)

189****7685 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档